Prostate Cancer - Results from #2720

Association between RCT methodology and disease indication with mineralocorticoid-related toxicity for patients receiving abiraterone acetate for advanced prostate cancer: A meta-analysis of RCTs. May 29, 2023

Multi-Gene Next-Generation Sequencing Panel for Analysis of BRCA1/BRCA2 and Homologous Recombination Repair Genes Alterations Metastatic Castration-Resistant Prostate Cancer. May 29, 2023

The long-term incidence and quality of life outcomes associated with treatment-related toxicities of external beam radiotherapy for prostate cancer. May 29, 2023

ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update. May 29, 2023

The Immunogenomic Landscape of Neuroendocrine Prostate Cancer. May 26, 2023

A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer. May 26, 2023

Hypofractionated, Dose Escalation Radiotherapy for High-Risk Prostate Cancer: the safety analysis of the Prostate Cancer Study-5 (PCS-5), a GROUQ led phase III trial. May 26, 2023

Treatment of Advanced Metastatic Prostate Cancer Using Molecular-Targeted Therapy: Radioligand Lutetium-177 Prostate-Specific Membrane Antigen. May 26, 2023

Insurer coverage of prostate cancer biomarkers. May 26, 2023

Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis. May 25, 2023

The Streaming Web-Based Exercise at Home Study for Breast and Prostate Cancer Survivors: A Feasibility Study Protocol. May 25, 2023

Re-sensitization to pembrolizumab following PSMA-CD3 T-cell redirection therapy with JNJ-081 in a patient with mismatch repair-deficient metastatic castration-resistant prostate cancer: a case report. May 25, 2023

Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate cancer men. May 25, 2023

Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer. May 25, 2023

Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate Cancer. May 25, 2023

Metastatic Hormone-Sensitive Prostate Cancer: Toward an Era of Adaptive and Personalized Treatment. May 25, 2023

On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans May 24, 2023

Post-diagnostic health behaviour scores and risk of prostate cancer progression and mortality. May 24, 2023

Assessment of Patients With Prostate Cancer and Their Understanding of the International Prostate Symptom Score Questionnaire. May 24, 2023

Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiation Therapy and Association of Metric Score With Rectal Toxicity Outcomes. May 24, 2023

Page 137 of 1439